The ruling spares the state from tens of millions of dollars of reimbursements over seven weeks and requires repayment only for services performed on or after Aug. 18.
U.S. District Judge Christina Snyder of Los Angeles had ruled Aug. 18 that the fee reductions threatened health care for many of Medi-Cal's 6.6 million low-income patients and appeared to violate federal standards for access to high-quality medical services. She ordered state officials to reimburse health care providers dating back to July 1, when the cuts took effect.
But after lawyers for the Medi-Cal program argued that the Constitution shields states from retroactive damage awards, Snyder revised her ruling Aug. 27 to eliminate the back payments and require full fees at pre-July 1 levels only from Aug. 18 onward. The state has asked a federal appeals court to overturn the entire ruling, arguing that federal law does not entitle Medi-Cal providers or patients to challenge fee levels in court.
State lawmakers approved the fee cuts in February, effective with the start of the fiscal year July 1. The Legislature remains in a partisan deadlock over the 2008-09 budget, which has a $17.2 billion deficit.
State officials had estimated that Snyder's original injunction - which covered fees to doctors, dentists, pharmacists, adult day health centers and clinics - would cost California $500 million a year. By that estimate, her Aug. 27 ruling would save the state $65 million. Because the fee reduction also applies to the federal government's 50 percent funding of Medi-Cal, the loss to health care providers would total $130 million.
"It's a blow to providers' ability to take care of the Medi-Cal population ... and a blow to the effort to insure that poor Californians have access to health care," Ned Wigglesworth, spokesman for the California Medical Association, said Wednesday.
Noting that many doctors already shun Medi-Cal because of low fees, Wigglesworth said, "If the state continues to insist on cutting health care during times of budget problems, providers are going to be less willing to participate."
Lynn Carman, lawyer for pharmacists, patients and community organizations that challenged the cuts in Medi-Cal prescription drug fees, said he would ask the appeals court to reinstate Snyder's original ruling and require reimbursement from July 1 onward. He renewed his accusation that state officials are dragging their feet on complying with the injunction, a subject of a hearing scheduled before Snyder on Friday.
Norman Williams, spokesman for the Department of Health Care Services, said the department has told its employees and contractors to "fully comply with the order" unless the judge agrees to suspend the injunction during the state's appeal.
Similar posts: oncology conference
- Mood:More emotions
- Music:Ami Suzuki
- Mood:Good
- Music:Namie Amuro
As a surgeon, robotic surgery enables me to remove the cancerous prostate from patients and help them return to a normal, healthy life, said Dr. Samadi. Instead of two to three days of hospitalization and two months of recuperation typical with open prostate surgery, robotic surgery patients often go home the next day and resume normal activities within two weeks.
During the webcast, Dr. Samadi will discuss the benefits of a robotic-assisted prostatectomy as compared to open and laparoscopic surgical procedures. Robotic prostate surgery is made possible with highly magnified visual enhancement technology in a bloodless field. This allows for greater precision in cutting and suturing with far less trauma to surrounding tissue, delicate nerve sparing, minimal blood loss, reduced risk of infection, and faster recovery. Patients experience improved clinical outcomes and increased control over their bladders and sexual functions.
Dr. Hall specializes in urologic oncology and open surgical techniques, and collaborates with Dr. Samadi on the treatment of prostate cancer for many of his patients.
I have seen the number of robotic prostatectomies increase among our patient population over the past couple of years and the benefits are quite clear, shared Dr. Hall. These surgeries result in fewer immediate complications and quicker recovery than in an open procedure, especially in the hands of a skilled surgeon who performs a high volume of cases routinely.
The Procedure:
Dr. Samadis robotic prostatectomy technique has evolved over the past 8 years starting with open surgery, moving to laparoscopy and finally to robotic surgery. Instead of making an 8 to 10 incision to remove a 2 prostate gland, Dr. Samadis robotic prostatectomy surgery involves just five small incisions in the patients abdomen, through which extremely fine instruments are inserted along with a miniscule camera that displays magnified two-dimensional images from inside the body onto a screen. The addition of the sophisticated da Vinci system transforms those images into 3D representations, which enables the surgeons hand movements to be scaled, filtered, and incredibly precise. This eliminates the touch factor or tactile feedback necessary to perform open surgery.
During the webcast, Dr. Samadi will highlight his unique advanced surgical techniques while performing a da Vinci Prostatectomy using the latest technologythe 4-arm da Vinci S Surgical System with high-definition 3D vision. The fourth robotic arm helps the surgeon by providing retraction to increase exposure of structures in the operative field. This arm also facilitates dissection by providing traction at the surgeons control.
Surgeon Experience:
Dr. Samadi is a board-certified urologic surgeon trained in open, laparoscopic, and robotic surgery. He is one of the worlds most experienced da Vinci surgeons with a record of high success. Dr. Samadi is one of the only surgeons in the country to have completed two fellowships: one in oncology (trained at Memorial Sloan Kettering Cancer Center in New York) and the other in laparoscopy (trained at Henri Mondor Hospital in France).
Dr. Samadi has completed more than 1,350 da Vinci cases in his career and since his arrival at Mount Sinai a year ago, he has performed nearly 550 robotic operations. Dr. Samadis robotic surgery program at Mount Sinai is unique for its ability to combine the advanced technology of robotics with the expertise of open and laparoscopic skills. For the series of surgeries performed at Mount Sinai, Dr. Samadis patients experienced an average blood loss of 63cc with a T2 positive margin of 7%. Eighty-five percent of his patients were able to wear one surgical pad or less just three months after surgery. The average length of hospital stay was one day with minimal complications and positive outcomes.
This program is paid for by Intuitive Surgical, manufacturer of the da Vinci S HD Surgical System.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center includes The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nations oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,406-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center. Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic-science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants. To learn more about Dr. Samadi and the Mount Sinai Medical Center, please visit http://www.roboticoncology.com or http://www.mountsinai.org.
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (NASDAQ: ISRG), headquartered in Sunnyvale, California, is the global technology leader in the emerging field of robot-assisted, minimally invasive surgery (MIS). Intuitive Surgical develops, manufactures and markets robotic technologies designed to improve clinical outcomes and help patients return more quickly to active and productive lives. The companys mission is to extend the benefits of minimally invasive surgery to the broadest possible base of patients. More information is available at http://www.intuitivesurgical.com and http://www.davincisurgery.com. Intuitive Surgical Taking surgical precision beyond the limits of the human hand
About the da Vinci Surgical System
The da Vinci Surgical System is a sophisticated robotic platform designed to enable complex surgery using a minimally invasive approach. The da Vinci System consists of an ergonomic surgeons console, a patient-side cart with four interactive robotic arms, a high-performance vision system and proprietary EndoWrist instruments. Powered by state-of-the-art robotic technology, the da Vinci System is designed to scale, filter and seamlessly translate the surgeons hand movements into more precise movements of the EndoWrist instruments. The net result is an intuitive interface with breakthrough surgical capabilities. By providing surgeons with superior visualization, enhanced dexterity, greater precision and ergonomic comfort, the da Vinci Surgical System makes it possible for more surgeons to perform minimally invasive procedures involving complex dissection or reconstruction. This ultimately raises the standard of care for complex surgeries, translating into numerous potential patient benefits, including less pain, a shorter recovery and quicker return to normal daily activities.
The presentation described is for general information only and is not intended to substitute for formal medical training or certification. An independent surgeon, who is not an Intuitive Surgical employee, provides procedure descriptions. Intuitive Surgical trains only on the use of its products and is not responsible for surgical credentialing or for training in surgical procedure or technique. As a result, Intuitive is not responsible for procedural content. While clinical studies support the use of the da Vinci Surgical System as an effective tool for minimally invasive surgery, individual results may vary.
Intuitive, da Vinci, InSite and EndoWrist are registered trademarks of Intuitive Surgical, Inc.
Similar posts: oncology conference
- Mood:More emotions
- Music:Southern All Stars
This call will provide information on accessing your 2007 PQRI Feedback Report (for those of you who participated in 2007); an overview of the 2008 PQRI participation options, and a question and answer session.
The Medicare, Medicaid, and SCHIP Extension Act of 2007 (MMSEA) (P.L. 110-173), which was enacted on December 29, 2007, requires that for 2008 and 2009 the Secretary establish alternative reporting periods and alternative criteria for satisfactorily reporting groups of measures. It also requires that for 2008 and 2009 the Secretary establish alternative reporting periods and alternative criteria for satisfactorily reporting quality measures data through registries.
In 2008, eligible professionals may earn an incentive payment of 1.5 percent of their total allowed charges for Physician Fee Service covered professional services furnished during the respective alternative reporting periods based on data submitted via these mechanisms. While TRHCA established a cap on incentive payments for 2007, based on an average per measure payment amount, there is no cap on incentive payments under MMSEA for 2008 and 2009.
These provisions provide increased opportunities for eligible professionals to report PQRI quality measures and the possibility to earn incentive payments for satisfactory reporting.
A PowerPoint slide presentation will be posted to the PQRI web page at http://www.cms.hhs.gov/PQRI/02_CMSSponso
Following the presentation, callers will have an opportunity to ask questions of CMS subject matter experts.
Conference call details:
Date: July 9, 2008
Conference Title: 2008 Physician Quality Reporting Initiative National Provider Call
Time: 3:30-5:00 (EDT)
In order to receive the call-in information, you must register for the call. It is important to note that if you are planning to sit in with a group, only one person needs to register to receive the call-in data. This registration is solely to reserve a phone line, NOT to allow participation. If you cannot attend the call, replay information is available below.
Registration will close at 3:30 p.m. (EDT) on July 8, 2008, or when available space has been filled. No exceptions will be made, so please be sure to register prior to this time.
To register for the call participants need to go to http://www2.eventsvc.com/palmettogba/070
Fill in all required data.
Verify your time zone is displayed correctly the drop down box.
Click "Register".
You will be taken to the Thank you for registering page and will receive a confirmation email shortly thereafter. Note: Please print and save this page, in the event that your server blocks the confirmation emails. If you do not receive the confirmation email, please check your spam/junk mail filter as it may have been directed there.
For those of you who will be unable to attend, a replay option will be available shortly following the end of the call. This replay will be accessible from 5:30 p.m. (EDT), 7/9/2008, until 11:59 p.m. (EDT), 7/16/2008. The call in data for the replay is (800) 642-1687 and the passcode is 52755102.
If you require services for the hearing impaired please send an email to Medicare.TTT@PalmettoGBA.com.
Read more...
- Mood:Cry
- Music:Mai Kuraki
The agreement was reached at the sixth Vietnam-RoK environment ministers’ conference held in Seoul on June 20, where the two countries underscored the importance of increased bilateral environmental cooperation to sustainable development.
Accordingly, the cope of the two countries’ future environmental cooperation will cover the sharing of experiences and information and the transfer of technology related to the protection and treatment of environmental pollution.
The two delegations to the conference also pledged to join efforts at international, regional and sub-regional environment-related forums, exchange viewpoints and consult each other on environment-related issues of mutual concern.
Minister of Natural Resources and Environment Pham Khoi Nguyen, apart from attending the conference, held talks with his RoK counterpart, Lee Maan-ee, affirming that environmental cooperation has been boosted along with the two countries’ mainstream cooperation.
The Vietnamese minister admitted that industrialisation has imposed great challenges to the country’s environment, requiring the undertaking of strategic renewals and breakthroughs and international cooperation.
He said the environment is one of the potential fields to be tapped by both countries, expressing hope for learning from RoK’s experiences in industrialisation.
Since 2004, the Vietnamese and RoK environment ministries have coordinated with related ministries and agencies to carry out many cooperative projects related to the environment.
Apart from signing a number of agreements, the two sides have initiated some big projects, including the project to build an environmental training centre in Vietnam with RoK’s ODA, the project to set up an air environment observing system, and the project to develop an E-manifest system to manage electronic wastes in Vietnam.
Read more...
- Mood:Cry
- Music:Southern All Stars
DVD Extra 2. House in the World of Nero Wolfe. A Distorted Genius Author Fic Commentary
A Distorted Genius is here.
Spoilers: for A Distorted Genius itself, minor plot points for House up to 4.11 Frozen, and books across Rex Stout's Wolfe corpus and the A E TV series.
This not a line by line fic commentary (to do that for 28K words might drive me mad). Instead it's a talk through how I approached it overall, with comments part by part, pointing out a few things of interest to me, my favourite lines, bits I wasn't so happy with, etc. Includes a short deleted House/Wilson piece of dialogue about Facebook.
Read more...
- Mood:Good
- Music:Southern All Stars
Oncology Times Hamilton Health Sciences (Hamilton ON): .performance will be considered as part of the selection process. This position is subject to the accommodation and/or redeployment process. MENLO PARK, Calif. BUSINESS WIRE Geron Corporation (Nasdaq:GERN) today announced two presentations of its anti-cancer drug, GRN163L, given at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. Oncology CHICAGO BUSINESS WIRE Radiation Therapy Oncology Group (RTOG) investigators and ImClone Systems Incorporated (Nasdaq: IMCL) today announced that adding the biologic agent cetuximab (ERBITUX) to chemotherapy and radiotherapy for . Oncology Reimbursement Solutions provides revenue cycle management expertise designed to improve oncology practice financial performance. Oncology Nursing Society HOUSTON, June 02, 2008 /PRNewswire/ -- Physicians affiliated with the US Oncology Research Network are presenting the results of their clinical research at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) held . BMS had signed a licensing agreement worth up to $400 million with respect to the companys epothilone compounds, of which $150 million targeted KOS-1584 oncology milestones, including regulatory approval Oncology Supply To about the decrepit payment of removing the cancerous reason tumor that threatens his existence, Kennedy went coupled with Friedman, a 59-year-old Chicago indigenous is a reverenced controller modern the nature of neuro-oncology who . Job title: Medical Manager, Project - Oncology; Location: Australia - New South Wales - Sydney; Company/ Division: Pharmaceuticals; Job function: Marketing; Job type: Standard; Schedule: Vollzeit; Job ad from: 03.06.2008 . Oncology Nursing Forum EAST HANOVER, NJ, June 2, 2008 /PRNewswire via COMTEX/ Early proof-of-concept studies presented today show RAD001 (everolimus) may offer a novel treatment strategy for breast cancer by enhancing the efficacy of, and overcoming . CHICAGO BUSINESS WIRE Investigators today presented data from a Phase 1, dose-escalation trial with ARQ 197, a selective inhibitor of the c-Met receptor tyrosine kinase under development by ArQule, Inc. (NASDAQ: ARQL) Oncology Times CHICAGO BUSINESS WIRE Amgen (NASDAQ: AMGN) today announced results from three denosumab studies in cancer patients. A Phase 2 study of metastatic patients previously treated with IV bisphosphonates found that denosumab normalized a . CHICAGO and TUSTIN, Calif., May 31 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. today reported that clinical researchers from the Abramson Cancer Center of the University of Pennsylvania will present data showing that its . Oncology EAST HANOVER, NJ, June 2 /PRNewswire/ -- Early proof-of-concept studies presented today show RAD001 (everolimus) may offer a novel treatment strategy for breast cancer by enhancing the efficacy of, and overcoming resistance to, . For the delicate task of removing the cancerous brain tumor that threatens his life, Kennedy went with Friedman, a 59-year-old Chicago native is a respected leader in the field of neuro-oncology who performs the majority of such . Oncology Nursing Society Undertaking a timely review of the principles that should underlie the role of surgery in malignant disease, this new textbook also discusses the relation of surgical oncology to the other medical specialties involved in the treatment . Department of Oncology and London Regional Cancer. Katharine Shim, Vascular Thrombembolic Events (VTEs) in Testicular Cancer Patients Receiving Chemotherapy Location: Room A3-924a/b. Oncology Supply Ahead of this week's Am. Soc. of Clinical Oncology meeting, which will draw some 25000 visitors to Chicago, IMS Health released its annual Global Oncology Forecast. It finds that while strong growth will continue worldwide in oncology . planning in prostate cancer patients because it eliminates the need for an invasive procedure and the related side effects, according to a study in the May 1 issue of the International Journal of Radiation Oncology*Biology*Physics Oncology Nursing Forum MARTINSRIED/MUNICH, Germany, June 2, 2008 - On the basis of convincing clinical data with EndoTAG-1 for the treatment of pancreatic cancer, the executive board of MediGene AG (Frankfurt, Prime Standard: MDG) has decided, with the. HOUSTON, June 2 /- Physicians affiliated with the US Oncology Research Network are presenting the results of their clinical research at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) held May 30 - June 3, .
Read more...
- Mood:Very good
- Music:Southern All Stars
Oncology Times Hamilton Health Sciences (Hamilton ON): .performance will be considered as part of the selection process. This position is subject to the accommodation and/or redeployment process. MENLO PARK, Calif. BUSINESS WIRE Geron Corporation (Nasdaq:GERN) today announced two presentations of its anti-cancer drug, GRN163L, given at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. Oncology CHICAGO BUSINESS WIRE Radiation Therapy Oncology Group (RTOG) investigators and ImClone Systems Incorporated (Nasdaq: IMCL) today announced that adding the biologic agent cetuximab (ERBITUX) to chemotherapy and radiotherapy for . Oncology Reimbursement Solutions provides revenue cycle management expertise designed to improve oncology practice financial performance. Oncology Nursing Society HOUSTON, June 02, 2008 /PRNewswire/ -- Physicians affiliated with the US Oncology Research Network are presenting the results of their clinical research at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) held . BMS had signed a licensing agreement worth up to $400 million with respect to the companys epothilone compounds, of which $150 million targeted KOS-1584 oncology milestones, including regulatory approval Oncology Supply To about the decrepit payment of removing the cancerous reason tumor that threatens his existence, Kennedy went coupled with Friedman, a 59-year-old Chicago indigenous is a reverenced controller modern the nature of neuro-oncology who . Job title: Medical Manager, Project - Oncology; Location: Australia - New South Wales - Sydney; Company/ Division: Pharmaceuticals; Job function: Marketing; Job type: Standard; Schedule: Vollzeit; Job ad from: 03.06.2008 . Oncology Nursing Forum EAST HANOVER, NJ, June 2, 2008 /PRNewswire via COMTEX/ Early proof-of-concept studies presented today show RAD001 (everolimus) may offer a novel treatment strategy for breast cancer by enhancing the efficacy of, and overcoming . CHICAGO BUSINESS WIRE Investigators today presented data from a Phase 1, dose-escalation trial with ARQ 197, a selective inhibitor of the c-Met receptor tyrosine kinase under development by ArQule, Inc. (NASDAQ: ARQL) Oncology Times CHICAGO BUSINESS WIRE Amgen (NASDAQ: AMGN) today announced results from three denosumab studies in cancer patients. A Phase 2 study of metastatic patients previously treated with IV bisphosphonates found that denosumab normalized a . CHICAGO and TUSTIN, Calif., May 31 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. today reported that clinical researchers from the Abramson Cancer Center of the University of Pennsylvania will present data showing that its . Oncology EAST HANOVER, NJ, June 2 /PRNewswire/ -- Early proof-of-concept studies presented today show RAD001 (everolimus) may offer a novel treatment strategy for breast cancer by enhancing the efficacy of, and overcoming resistance to, . For the delicate task of removing the cancerous brain tumor that threatens his life, Kennedy went with Friedman, a 59-year-old Chicago native is a respected leader in the field of neuro-oncology who performs the majority of such . Oncology Nursing Society Undertaking a timely review of the principles that should underlie the role of surgery in malignant disease, this new textbook also discusses the relation of surgical oncology to the other medical specialties involved in the treatment . Department of Oncology and London Regional Cancer. Katharine Shim, Vascular Thrombembolic Events (VTEs) in Testicular Cancer Patients Receiving Chemotherapy Location: Room A3-924a/b. Oncology Supply Ahead of this week's Am. Soc. of Clinical Oncology meeting, which will draw some 25000 visitors to Chicago, IMS Health released its annual Global Oncology Forecast. It finds that while strong growth will continue worldwide in oncology . planning in prostate cancer patients because it eliminates the need for an invasive procedure and the related side effects, according to a study in the May 1 issue of the International Journal of Radiation Oncology*Biology*Physics Oncology Nursing Forum MARTINSRIED/MUNICH, Germany, June 2, 2008 - On the basis of convincing clinical data with EndoTAG-1 for the treatment of pancreatic cancer, the executive board of MediGene AG (Frankfurt, Prime Standard: MDG) has decided, with the. HOUSTON, June 2 /- Physicians affiliated with the US Oncology Research Network are presenting the results of their clinical research at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) held May 30 - June 3, .
Americano new top 10 >>> oncology conference
- Mood:Good
- Music:Sukiyaki
- Mood:Good
- Music:Chage and Aska
5/2/2008
HOUSTON, May 1 /PRNewswire/ -- US Oncology Holdings, Inc. and its operating subsidiary, US Oncology, Inc., will announce 2008 first quarter financial results on Thursday, May 8, 2008.
A conference call and simultaneous webcast has been scheduled at 11:00 a.m., EDT, for the company's bondholders following the distribution of the news release. In this call, representatives of US Oncology's management team will discuss the financial results. Further information can be found on the company's Web site, http://www.usoncology.com, in the "News Center" on the day of the earnings announcement.
About US Oncology, Inc.
US Oncology, headquartered in Houston, Texas, is one of the nation's largest cancer treatment and research networks. US Oncology provides extensive services and support to its affiliated cancer care sites nationwide to help them expand their offering of the most advanced treatments and technologies, build integrated community-based cancer care centers, improve their therapeutic drug management programs and participate in many of the new cancer-related clinical research studies. US Oncology also provides a broad range of services to pharmaceutical manufacturers, including product distribution and informational services such as data reporting and analysis.
According to the company's last quarterly earnings report, US Oncology is affiliated with 1,199 physicians operating in 461 locations, including 88 radiation oncology facilities in 39 states.
CONTACT: Kevin F. Krenzke of US Oncology Holdings, Inc., +1-832-601-6197,
kevin.krenzke@usoncology.com
Web site: http://www.usoncology.
News the best top 10 >>> oncology conference
- Mood:Good
- Music:Heartbreak Hotel
- Mood:Very good
- Music:Sukiyaki
- Mood:Good
- Music:Heartbreak Hotel
PIPELINES IN ONCOLOGY - Glaxo SmithKline
A series of product development presentations sponsored by DF/HCC
PRESENTED BY: GLAXO SMITHKLINE
Presented by:
Peter Ho, MD, PhD Senior Vice President Oncology CEDD
Barbara Weber, MD, Vice President of Discovery and Translational Medicine
TOPICS/PRODUCTS TO BE PRESENTED:
Decision-making process in Drug Development at GSK
GSK Pipeline and Translation Efforts
April 24, 2008, 2008, 4:00 - 5:30 PM
Dana-Farber Cancer Institute, Dana 1620
Video Conference to MGH Lawrence House 2nd floor conference room
These presentations are not for the public and designated for members of the DF/HCC institutions only.
PARKING: Please park in DFCIs Smith Garage at One Jimmy Fund Way.
DFCI will validate parking for the event.
See more: >>> oncology conference
- Mood:Good
- Music:Mai Kuraki
American Society For Therapeutic Radiology And Oncology Receives Record Number Of Abstracts For 50th Annual Meeting
The American Society for Therapeutic Radiology and Oncology has received a record number of abstract submissions for the scientific program to be held at its 50th Annual Meeting taking place September 21-25, 2008, in Boston.
Source: www.medicalnewstoday.com
Protein Data Bank Archives 50,000th Molecule Structure
The Protein Data Bank (PDB) based at Rutgers, The State University of New Jersey, and the University of California-San Diego (UCSD) this month reached a significant milestone in its 37-year history. The 50,000th molecule structure was released into its archive, joining other structures vital to pharmacology, bioinformatics and education.
Source: www.medicalnewstoday.com
Teenage Birth Rates In Massachusetts Highest Among Hispanics; Legislation Needed To Address The Issue, Experts Say
Births to Hispanic teenagers living in the western part of Massachusetts -- a state with one of the lowest teen pregnancy rates in the nation -- are more prevalent than teen births among other groups and the rate is growing, a health expert said at a conference on Monday, the Springfield Republican reports.
Source: www.medicalnewstoday.com
FDA Reports More Deaths Linked To Contaminated Heparin
The US Food and Drug Administration released an update yesterday, 8th April, showing a dramatic rise in the number of deaths that may be due to patients having allergic reactions to contaminated heparin. The agency puts the new figure at 62 deaths in the last 15 months, which is considerably more than the 19 suggested last month.
Source: www.medicalnewstoday.com
Chlorine Triggers Protective Nerve Receptor
Inhaling chlorine triggers a nerve receptor that protects healthy people by inducing sneezing, coughing, and irritation, but can cause major problems for people with asthma and other respiratory problems, Yale School of Medicine researchers report in the Journal of Clinical Investigation.
Source: www.medicalnewstoday.
oncology conference <<< hot news
- Mood:Good
- Music:Heartbreak Hotel
- Mood:Good
- Music:Heartbreak Hotel
American Society For Therapeutic Radiology And Oncology Receives Record Number Of Abstracts For 50th Annual Meeting
The American Society for Therapeutic Radiology and Oncology has received a record number of abstract eubmissiins for the sscienticic program t be held at its 50th Anmual Meeting taking place September 21-25, 2008, in Boston.
Source: www.medicalnewstoday.com
Protein Data Bank Archives 50,000th Molecule Structure
The Protein Data Bank (PB) based at Rutgers, The State University of Nee Jersey, and the University kf California-San Diego (UCSD) this month reached a significant milestone kn its 37-year history. The 50,000th molecule stgucture was released into its archive, joining other structures vital to pharmacology, bioinformatics and education.
Source: www.medicalnewstoday.com
Teenage Birth Rates In Massachusetts Highest Among Hispanics; Legislation Needed To Address The Issue, Experts Say
Births to Hispanic teenagers living in the western part of Massachusetts -- state witb one of the lowest teen pregnancy rates kn the nation -- are more prevalent than teen births amkng other groups and tthe rate is growing, a health expert eaid at a conference on Monday, the Springfield Rephblican reports.
Source: www.medicalnewstoday.com
FDA Reports More Deaths Linked To Contaminated Heparin
The US Food and Administration released am update yesterday, 8th April, showing a dramatic rise in the nkmber deaths that may be dye to patiebts having allergic reactions to contamknated heparin. The agency puts the nes figure at 662 deaths in the last 1 months, wnich is cinsiderably more than the 19 suggested last month.
Source: www.medicalnewstoday.com
Chlorine Triggers Protective Nerve Receptor
Inhaling ctlorine triggers a nerve receptor that protects healthy people by inducing sneezing, cough ing, and itritation, but can cause major problems for people with asthma and othsr respiratory pgoblems, Yale School of Medicine researchers report in tt e Journal of Clinical Investigation.
Source: www.medicalnewstoday.
All information >>> oncology conference
- Mood:Good
- Music:Ami Suzuki
- Mood:Cry
- Music:Chage and Aska
- Mood:Very good
- Music:Mai Kuraki
Los Angeles, CA (PRWEB) March 24, 2008 University of California, Los Angeles (UCLA) Neuro-Oncology Program to host 8th Annual Brain Tumor Conference, April 18th 19th, 2008.
This years conference aims to connect brain cancer patients, survivors and family members with leading experts in the fields of Neuro-Oncology, Neurosurgery, Neurology, Radiation Oncology, Nutrition, Genetics, Psychiatry, Psychology, Radiology, Neuropathology and Medical Informatics.
The free two day conference will offer participants the opportunity to hear leading healthcare professionals speak about the latest treatments for brain tumors, how brain tumors work and issues related to quality of life, nutrition and mental health. Through this conference, the Neuro-Oncology Programs will promote the sharing of information and experiences between brain tumor survivors, their families, friends and health care professionals.
The meeting will be held April 18th 19th, 2008 on the UCLA campus at Bradley International Hall.
The conference is free and pre-registration is required. Early registration is encouraged as conference space and materials are limited. Conference Participants may register securely online and view updated conference schedule and events by visiting http://neurooncology.ucla.
More info about >>> oncology conference
- Mood:Good
- Music:Mai Kuraki
admin wrote an interesting post today on
Heres a quick excerpt
HOLLYWOOD, Fla.(BUSINESS WIRE)Mar 27, 2008 - The 21st century will be a time of personalized care for patients with breast cancer where tools such as biomarkers, multi-gene assays and single-gene assays will help clinicians individualize treatment, according to Peter Ravdin, M.D., Ph.D presenting at the NCCN 13th Annual Conference.
oncology conference <<< hot news
- Mood:Very good
- Music:Namie Amuro
Profile
![[info]](http://l-stat.livejournal.com/img/userinfo.gif)
healthyalways- healthyalways
Syndicate
